BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 20689544)

  • 1. Neutrophils release brakes of coagulation.
    Ruf W; Ruggeri ZM
    Nat Med; 2010 Aug; 16(8):851-2. PubMed ID: 20689544
    [No Abstract]   [Full Text] [Related]  

  • 2. Reciprocal coupling of coagulation and innate immunity via neutrophil serine proteases.
    Massberg S; Grahl L; von Bruehl ML; Manukyan D; Pfeiler S; Goosmann C; Brinkmann V; Lorenz M; Bidzhekov K; Khandagale AB; Konrad I; Kennerknecht E; Reges K; Holdenrieder S; Braun S; Reinhardt C; Spannagl M; Preissner KT; Engelmann B
    Nat Med; 2010 Aug; 16(8):887-96. PubMed ID: 20676107
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early recruited neutrophils promote asthmatic inflammation exacerbation by release of neutrophil elastase.
    Weng Q; Zhu C; Zheng K; Wu Y; Dong L; Wu Y; Li M; Shen J; Ying S; Shen H; Chen Z; Li W
    Cell Immunol; 2020 Jun; 352():104101. PubMed ID: 32278493
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The role of tissue factor pathway inhibitor (TFPI) in thrombotic complications].
    Gosk-Bierska I; Adamiec R
    Pol Arch Med Wewn; 2005 Aug; 114(2):792-8. PubMed ID: 16808319
    [No Abstract]   [Full Text] [Related]  

  • 5. Interactions of neutrophils and coagulation proteins.
    Gillis S; Furie BC; Furie B
    Semin Hematol; 1997 Oct; 34(4):336-42. PubMed ID: 9347584
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of coagulation inhibitors in inflammation.
    Esmon CT
    Thromb Haemost; 2001 Jul; 86(1):51-6. PubMed ID: 11487041
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recombinant tissue factor pathway inhibitor enhances the binding of factor Xa to human monocytes.
    Li A; Chang AC; Peer GT; Wun TC; Taylor FB
    Thromb Haemost; 2001 May; 85(5):830-6. PubMed ID: 11372676
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral medications affecting blood coagulation.
    Kloch SM; Kloch GM
    Plast Surg Nurs; 1984; 4(2):52-5. PubMed ID: 6565289
    [No Abstract]   [Full Text] [Related]  

  • 9. [Leukocyte elastase in blood plasma from tuberculosis patients and its role in disturbances of blood coagulation regulatory processes].
    Dotsenko VL; Spirina AIa; Makinskiĭ AI; Neshkova EA; Ershikova IuE; Iarovaia GA
    Vopr Med Khim; 2000; 46(2):176-83. PubMed ID: 10885039
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of neutrophil elastase in hypersecretion in asthma.
    Nadel JA; Takeyama K; Agustí C
    Eur Respir J; 1999 Jan; 13(1):190-6. PubMed ID: 10836347
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sepsis-induced coagulation in the baboon lung is associated with decreased tissue factor pathway inhibitor.
    Tang H; Ivanciu L; Popescu N; Peer G; Hack E; Lupu C; Taylor FB; Lupu F
    Am J Pathol; 2007 Sep; 171(3):1066-77. PubMed ID: 17640967
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neutrophils promote the release of alpha-6-fucosyltransferase from blood platelets through the action of cathepsin G and elastase.
    Kamińska J; Musielak M; Nowicka A; Wozniewicz B; Kościelak J
    Biochimie; 2001 Aug; 83(8):739-42. PubMed ID: 11530205
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human leukocyte elastase and cathepsin G are specific inhibitors of C5a-dependent neutrophil enzyme release and chemotaxis.
    Tralau T; Meyer-Hoffert U; Schröder JM; Wiedow O
    Exp Dermatol; 2004 May; 13(5):316-25. PubMed ID: 15140022
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vascular repair utilising immobilised heparin conjugate for protection against early activation of inflammation and coagulation.
    Nordling S; Hong J; Fromell K; Edin F; Brännström J; Larsson R; Nilsson B; Magnusson PU
    Thromb Haemost; 2015 Jun; 113(6):1312-22. PubMed ID: 25740465
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of tissue factor pathway inhibitor in the regulation of tissue factor-dependent blood coagulation.
    Golino P; Ragni M; Cimmino G; Forte L
    Cardiovasc Drug Rev; 2002; 20(1):67-80. PubMed ID: 12070535
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tissue factor pathway inhibitor does not influence inflammatory pathways during human endotoxemia.
    de Jonge E; Dekkers PE; Creasey AA; Hack CE; Paulson SK; Karim A; Kesecioglu J; Levi M; van Deventer SJ; van der Poll T
    J Infect Dis; 2001 Jun; 183(12):1815-8. PubMed ID: 11372037
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Oral anticoagulant treatment; which anticoagulant?].
    Thijssen HH; Hemker HC
    Ned Tijdschr Geneeskd; 1984 Aug; 128(33):1559-63. PubMed ID: 6483024
    [No Abstract]   [Full Text] [Related]  

  • 18. Tissue factor pathway inhibitor in thrombosis and beyond.
    Mousa SA; Fareed J; Iqbal O; Kaiser B
    Methods Mol Med; 2004; 93():133-55. PubMed ID: 14733332
    [No Abstract]   [Full Text] [Related]  

  • 19. [Vitamin K antagonists].
    Chabalier R; Lévy G
    Ann Anesthesiol Fr; 1978; 19(10):IN-5N. PubMed ID: 35048
    [No Abstract]   [Full Text] [Related]  

  • 20. Leukocyte elastase: physiological functions and role in acute lung injury.
    Lee WL; Downey GP
    Am J Respir Crit Care Med; 2001 Sep; 164(5):896-904. PubMed ID: 11549552
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.